ORGO CIK: 1661181

Organogenesis Holdings Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
227
FY22:
223
FY23:
225
FY24:
286
FY25:
362
(positive)
Change from FY21 to FY25
millions USD
FY21:
216
FY22:
227
FY23:
235
FY24:
212
FY25:
237
Total assets
Change from FY21 to FY25
millions USD
FY21:
443
FY22:
449
FY23:
460
FY24:
498
FY25:
599

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
82.7
FY22:
75.0
FY23:
80.5
FY24:
77.5
FY25:
100
(negative)
Change from FY21 to FY25
millions USD
FY21:
119
FY22:
109
FY23:
101
FY24:
35.1
FY25:
64.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
241
FY22:
266
FY23:
279
FY24:
263
FY25:
300
Total liabilities & equity
Change from FY21 to FY23
millions USD
FY21:
443
FY22:
449
FY23:
460
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR